Bayer HealthCare

Bayer is a large multinational company that has a subsidiary, Bayer Healthcare which has a Pharmaceuticals branch responsible for the manufacture of Finacea.

Recent Rosacea Blog Posts

Leo Pharma is the new owner of Finacea

News today that Bayer HealthCare is selling its prescription dermatology business to the unlisted Danish company Leo Pharma. Leo Pharma now becomes an interesting company for rosacea sufferers given the prevalence and efficacy of both Finacea and Finacea Foam. The future of these products and any related funded research now rests with Leo Pharma. LEO […]

Continue Reading

Finacea Foam makes $680K for Foamix

A recent press release from Foamix gives a view into how well Finacea Foam is selling. Based on Q1 2016 sales of the newly approved Finacea Foam, Bayer HealthCare made a royalty payment of $682,000 to Foamix as a fee for licensing their foaming technology. Along with the comment that Finacea Foam sales are continuing […]

Continue Reading

Oracea and Finacea prescription prices are increasing !

The JAMA Dermatology has just published a summary of the trend in prescription prices from 2009 to 2015. The news is not good. Overall the brand-name prescriptions increased in price FOUR FOLD during this period. Four national chain pharmacies in the West Palm Beach, Florida, area—specifically, Costco, CVS, Sam’s Club, and Walgreens—were initially surveyed in […]

Continue Reading

Finacea vs. Metrogel and Mirvaso–Fight!

A recently listed Clinical Trial aims to recruit rosacea sufferers to find out how well they are getting on with their usage of Finacea, Metrogel and Mirvaso. The trial outcomes are several, but include the recording of adverse reactions to treatments, patient satisfaction and likelihood of switching rosacea treatment. The trial is being sponsored by […]

Continue Reading

Finacea Foam (azelaic acid 15%) User Reviews

News today that the FDA has approved the azelaic acid based Finacea Foam. FDA Approves Bayer’s Finacea (azelaic acid) Foam, 15% for the Topical Treatment of the Inflammatory Papules and Pustules of Mild to Moderate Rosacea WHIPPANY, N.J., July 31, 2015 /PRNewswire/ — Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.